Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

NCT05911750 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 384

Last updated 2025-09-12

No results posted yet for this study

Summary

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.

Conditions

Interventions

DIAGNOSTIC_TEST

Anal pap smear and oral swab for cytology and HPV testing

Anal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-12
Primary Completion
2026-01-31
Completion
2026-06-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05911750 on ClinicalTrials.gov